dwinnex.com

Flex Pharma, Inc. [NASDAQ: FLKS] shares went higher by 19.09% from its previous closing of $0.54, now trading at the price of $0.64, also adding 0.1 points. Is FLKS stock a buy or should you stay away?

The stock had a rather active trading session with the latest closing, by far recording 4.67 million contracts. Compared to the average trading volume of FLKS shares, the company saw a far better performance. Moreover, the stock has a 15.64M float and a +30.61% run over in the last seven days. FLKS share price has been hovering between $1.74 and $0.26 lately, and is definitely worthy of attention.

Flex Pharma, Inc. [NASDAQ:FLKS]: Analyst Rating and Earnings

Stock market traders oftentimes pay a lot of attention to what top analysts say regarding a potential investment. Its stock price has been found in the range of 0.26 to 1.74. This is compared to its latest closing price of $0.54.

Pay attention for this company’s financial results, of which the next release is scheduled to happen on Wed 7 Aug (In 54 Days).

Fundamental Analysis of Flex Pharma, Inc. [FLKS]

Now let’s turn to look at profitability: with a current Operating Margin for Flex Pharma, Inc. [FLKS] sitting at -2467.91 and its Gross Margin at +48.61.

This company’s Return on Total Capital is -107.76, and its Return on Invested Capital has reached -237.40%. Its Return on Equity is -114.21, and its Return on Assets is -96.61. These metrics suggest that this Flex Pharma, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

What about valuation? This company’s Enterprise Value to EBITDA is 0.02. The Enterprise Value to Sales for this firm is now -0.59. Flex Pharma, Inc. [FLKS] has a Price to Book Ratio of 0.64.

Shifting the focus to workforce efficiency, Flex Pharma, Inc. [FLKS] earns $209,536 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 82.48 and its Total Asset Turnover is 0.04. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 9.15 and its Current Ratio is 9.32. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Flex Pharma, Inc. [FLKS] has 16.92M shares outstanding, amounting to a total market cap of $10.83M. Its stock price has been found in the range of 0.26 to 1.74. At its current price, it has moved down by -63.22% from its 52-week high, and it has moved up 146.15% from its 52-week low.

This stock’s Beta value is currently 1.55, which indicates that it is 14.02% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 74.01. This RSI suggests that Flex Pharma, Inc. is currently Overbought.

Conclusion: Is Flex Pharma, Inc. [FLKS] a Reliable Buy?

Shares of Flex Pharma, Inc. [FLKS], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.